In cell culture research, IGF-1 LR3 has largely displaced native IGF-1 as the growth factor of choice. The reason is a story about binding proteins.
The Binding Protein Problem
In biological systems, insulin-like growth factor 1 rarely travels alone — six IGF-binding proteins capture and buffer it, controlling its availability. For a researcher adding IGF-1 to a culture, those binding proteins are noise: they sequester the added factor unpredictably.
The LR3 Solution
IGF-1 LR3 carries two modifications: an arginine at position 3 and a 13 amino acid N-terminal extension. Together they slash binding-protein affinity while preserving IGF-1 receptor activation — the added factor stays free, active, and dose-predictable, which is exactly what a controlled proliferation study needs.
What Laboratories Do With It
The literature spans muscle cell proliferation and differentiation, general mitogenic assays, and IGF-1 receptor signaling studies. It also intersects the growth hormone axis — IGF-1 being the downstream effector that compounds like Tesamorelin and Sermorelin ultimately elevate in axis research. Find it in the Growth Hormone collection.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.
